Corrigendum to "A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone": [ESMO Open 8 (2023) 102033]
对“曲妥珠单抗德鲁替康治疗晚期 HER2 阳性乳腺癌的疗效比较:活动性脑转移与单纯进展性颅外疾病”的更正:[ESMO Open 8 (2023) 102033]
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.103621
Pearson, J; Khan, A; Bhogal, T; Wong, H; Law, A; Mills, S; Santamaria, N; Bishop, J; Cliff, J; Errington, D; Hall, A; Hart, C; Malik, Z; Sripadam, R; Innes, H; Flint, H; Langton, G; Ahmed, E; Jackson, R; Palmieri, C